Status:
COMPLETED
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies
Lead Sponsor:
Case Comprehensive Cancer Center
Conditions:
Hepatic Malignancies
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the results of positron emission tomography/computer tomography (PET/CT) to positron emission tomography/magnetic resonance imaging (PET/MRI) to help determine ...
Detailed Description
Participants in this study will undergo PET/CT (standard imaging) and PET/MR (additional imaging), within 6 hours after SIRT with Y-90 for palliative treatment of the liver malignancy. Patients will b...
Eligibility Criteria
Inclusion
- The patient has a liver malignancy and is scheduled for SIRT with Y-90; AND
- The patient is an adult, self-competent, and able to provide informed consent to participate in the study
Exclusion
- The patient loses competence, has a condition that questions their ability to provide informed consent independently (e.g. cannot communicate in English), or withdraws consent to participate within any time in the study period; OR
- The patient is not eligible to undergo MRI due to the presence of metal devices or implants in their body; OR
- Both imaging modalities cannot take place within 6 hours after Y-90 RE; OR
- Both imaging modalities cannot take place within 1 hour apart from each other
Key Trial Info
Start Date :
March 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04332419
Start Date
March 3 2020
End Date
September 21 2020
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44122